Archive for 2012

Losing Weight Techniques Calories In Calories Out

Monday, December 31, 2012

Loosing weight is a challenged but it can be achieved, the main focus on weight lost should be calories in and calories out, that simple means eat less. Lets do some simple maths, 3500 calories make 1 pound try and eat 500 calories less a day and in one week you will loose one pound.



You can loose weight true exercise which helps to strengthen  the muscles and burn calories in the process, walking is a great exercise you can burn up to 305 calories by walking for one hour. You don't have to walk one straight hour you can walk 30 minutes in the morning, 15 minutes in your lunch time and 15 minutes in the evenings.




Swimming is a great exercise to loose but you have to be careful in the water at all times. You can loose up to 632 calories a hour swimming. You can swim 10 minutes at a time if you cant go the full hour straight. and please remember be careful in the water.




Rope jumping (skipping) is my favorite form of exercise, you burn calories real fast when you jump rope you can loose up to 1,286 calories a hour jumping rope. It will take some practice but as time goes by you will be good at it. What i do is jump six set of ten minutes at day, i do 20 minutes in the morning, 20 minutes at noon and 20 in the evening. And i can tell you that it really works.



There are other types of exercise that you can use to achieve your weight lost goals but the main thing in weight lost is to burn more calories than what you take in.  
Read more

Comments Off

Focus On Cancer Year in Review: Immunotherapy for Leukemia

· Posted in ,


2012 was an exciting year for the Abramson Cancer Center. We are featuring blogs featured on the Focus On Cancer blog that highlight cancer treatment breakthroughs, coping tips and ideas, education and inspiration. Today, we are highlighting the immunotherapy and leukemia.

A front-page story in the New York Times details the progress of a Perelman School of Medicine team in using genetically engineered versions of leukemia patients' own T cells to fight their cancer; an approach which has now been used in 12 patients, 9 of whom responded to the therapy -- including two children.

Immunotherapy for Leukemia

A front-page story in the New York Times details the progress of a Perelman School of Medicine team in using genetically engineered versions of leukemia patients' own T cells to fight their cancer; an approach which has now been used in 12 patients, 9 of whom responded to the therapy -- including two children.

"Our goal is to have a cure, but we can't say that word," said the study's leader, Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in Penn's Abramson Cancer Center.

He hopes the new treatment will eventually replace bone-marrow transplantation, an even more arduous, risky and expensive procedure that is now the last hope when other treatments fail in leukemia and related diseases.

Cancer Information From a Reliable Source

The Focus On Cancer blog is committed to provide people with cancer and their caregivers educated information from a reliable source, the Abramson Cancer Center at Penn Medicine. Please subscribe to our blog to get updates about new cancer treatments at Penn, credible information from cancer experts at Penn, and inspiration from other people with cancer.
Read more

Comments Off

Focus On Cancer Year in Review: Stand Up 2 Cancer and Penn

Friday, December 28, 2012 · Posted in


2012 was an exciting year for the Abramson Cancer Center. We are featuring blogs featured on the Focus On Cancer blog that highlight cancer treatment breakthroughs, coping tips and ideas, education and inspiration. Today, we are highlighting the partnership between the Stand Up 2 Cancer Foundation and Penn Medicine.

The SU2C Dream Team at Penn is actively researching better ways to prevent, diagnose and treat pancreatic cancer. Together, members of the Pancreatic Cancer Dream Team working to translate scientific breakthroughs into new treatment options faster than ever before.

About Stand Up 2 Cancer

Founded in 2008, SU2C has raised more than $180 million for innovative cancer research. Since its inception, SU2C has made grants to seven multi-disciplinary “Dream Teams” of researchers as well as to 26 young innovative scientists who are undertaking potentially high-reward projects to end the reign of cancer as a leading cause of death in the world today.

Eighty-five institutions are currently involved, including Penn Medicine’s Abramson Cancer Center.

The Penn Medicine SU2C Dream Team

As the fourth leading cause of cancer death in the United States, pancreatic cancer remains one of the most deadly forms of cancer. More than 90 percent of patients die within the first year of diagnosis. Recent advancements have had little impact, and a new approach is desperately needed.

The SU2C Dream Team at Penn is actively researching better ways to prevent, diagnose and treat pancreatic cancer. Together, members of the Pancreatic Cancer Dream Team working to translate scientific breakthroughs into new treatment options faster than ever before. Their research focuses on developing tests using advanced imaging technology to understand pancreatic cancer cells and developing new, personalized pancreatic cancer treatments based on their research.

Members of the Pancreatic Cancer SU2C Dream Team at Penn Medicine

Pancreatic cancer researchers at Penn Medicine are at the forefront of developing new, personalized approaches to pancreatic cancer treatment.

These Penn clinicians and researchers are part of the SU2C Pancreatic Cancer Dream Team.

Chi Van Dang, MD, PhD
Professor of Medicine, Hematology/Oncology
Director, Abramson Cancer Center
Director, Abramson Family Cancer Research Institute

Jeffrey A. Drebin, MD, PhD, FACS
John Rhea Barton Professor of Surgery
Chairman, Department of Surgery

Hank Kung, PhD
Professor of Radiology and Pharmacology
Department of Radiology
Perelman School of Medicine

Peter J. O’Dwyer, MBBCh, MD
Professor of Medicine, Hematology/Oncology
Perelman School of Medicine

Watch Stand Up 2 Cancer and Join the Conversation

Watch Stand Up to Cancer on Friday, September 7 at 8 pm ET, and join Penn Medicine on Twitter as we discuss pancreatic cancer and its treatment at Penn Medicine, and how researchers and clinicians on the SU2C Pancreatic Cancer Dream Team are changing the way cancer is treated today.

Cancer Information From a Reliable Source

Thank you for a fantastic 2012. The Focus On Cancer blog is committed to provide people with cancer and their caregivers educated information from a reliable source, the Abramson Cancer Center at Penn Medicine. Please subscribe to our blog to get updates about new cancer treatments at Penn, credible information from cancer experts at Penn, and inspiration from other people with cancer.
Read more

Comments Off

Navigating the Way to Colorectal Screenings at Penn

Thursday, December 27, 2012 · Posted in

Colorectal cancer is the second most common cause of cancer deaths in the United States. Although studies prove that screening reduces colorectal cancer morbidity and mortality and is recommended for everyone over the age of 50, only 60 percent of Americans have been screened.
Penn Medicine’s West Philadelphia Gastrointestinal (GI) Health Outreach and Access Program has worked to to improve the colorectal cancer screening rates in the West Philadelphia community.

Founded in November 2011 with seed funding from an anonymous donor, the Abramson Cancer Center of the University of Pennsylvania established the program, which provides education about colorectal cancer screening and physical navigation through the screening process for people who live in the following zip codes:
  • 19104
  • 19131
  • 19139
  • 19143
  • 19151
Patient navigator, Alicia Lamanna, works with patients on a one-on-one basis and addresses barriers that might prevent them from getting a screening test. She also ensures patients understand the information by using language that is easy to comprehend.

Assisting patients every step of the way

The patient navigation program is committed to providing every patient the assistance and encouragement they need throughout the entire screening process.

The program provides the following:

  • Help with scheduling a colonoscopy
  • Education about the screening including literature, instructions for the screening preparation and motivational information
  • Encouragement and support
  • Reminder phone calls about the screening appointment
  • Instructions for the day of screening
  • Miralax-Dulcolax-Crystal Light prep free of charge
  • Transportation assistance with Septa tokens
  • Accompaniment to and from the screening exam
Finally, one week after the procedure, Alicia, communicates the physician's findings and recommendations both verbally and in writing to everyone who participates in the screening.

To qualify for the program patients must:
  1. Be between the ages of 50 and 75
  2. Live in one of the five participating West Philadelphia zip codes
  3. Have an order or prescription for a colonoscopy from your Penn primary care physician

Whether the reasons are financial, insurance or personal — such as being embarrassed or nervous — that keep someone from getting a colorectal screening, the outreach program provides the assistance needed to obtain this life-saving screening.

Patient Navigation Works

A study to determine the feasibility, acceptability and use of the program was recently completed.

Of the 125 patients who completed a screening colonoscopy through this program, 46 (37%) were found to have at least one adenomatous (precancerous) polyp and 3 patients were found to have cancer 1 primary colorectal cancer, 1 metastatic breast cancer, 1 currently unknown origin (unpublished data). These results show that this program has great potential to prevent colorectal cancer.

In addition, satisfaction with the program has been high, with 92% strongly agreeing with the statement: “Overall, I am satisfied with the navigation services I received from the navigator.”

In addition, 36% of the patients who completed the program stated they would have been, “highly unlikely to have completed the colonoscopy without the patient navigator.”

Get More Information

For more information about the program and preventing colorectal cancer, visit the 2012 CANPrevent Colorectal Cancer Conference from the Abramson Cancer Center, or call Alicia Lamanna at 215-439-8281.

As an American College of Surgeons Commission on Cancer accredited Center, Penn’s Abramson Cancer Center is pleased to share these results with the public.

Read more

Comments Off

Focus On Cancer Year in Review: New Brain Cancer Treatments at Penn

Wednesday, December 26, 2012 · Posted in ,


2012 was an exciting year for the Abramson Cancer Center. We are featuring blogs featured on the Focus On Cancer blog that highlight cancer treatment breakthroughs, coping tips and ideas, education and inspiration. Today, we are highlighting the brain cancer treatment at Penn.

There are new treatments for brain cancer at Penn. In this article, writer and cancer survivor Chris Wilson discusses new treatments in surgery, radiation and targeted therapies for brain cancer.

New Treatments for Brain Cancer


Christine Wilson, cancer survivor, shares her experiences from the Abramson Cancer Center’s 2012- Focus on Brain Cancer Conference:
Discovery to Recovery. In this blog, she discusses treatments for brain cancer.

Neurosurgery:  The Crux of Treatment for Brain Cancer


"The neurosurgeon's goal is take out as much of the tumor as possible safely, " says Steven Brem, MD, conference chair, and director of neurosurgical oncology.

"Personalized medicine has become something of a buzz work in medicine, but it is true for brain cancer patients,” says  Donald O'Rourke, MD, associate professor of neurosurgery.

Penn neurosurgeons are using improved imaging techniques for "neuronavigation."  This approach provides real-time, 3D views for the surgeon as he operates - allowing for maximum safe resection of the tumor and avoiding normal tissue.  This is particularly crucial in preserving language function and motor skills.

Radiation Therapy:  The Full Spectrum of Options


"Penn has the largest, most advanced proton facility in the world, one of only 10 in the United States.  We also have the unique advantage of having all of our radiation facilities integrated under one roof, "
Robert Lustig, MD, professor of radiation oncology.

Radiation therapy plays a key role in the treatment of most brain cancers.  Penn offers the full range of treatment modalities including one of only 10 proton facilities in the country.  Patients often are unsure of the relative benefits or indications for different kinds of radiation therapy, for example, protons vs. the gamma or cyber knife. 

Radiation therapy treatment decisions for brain tumors are highly individualized and need to be made in the context of multidisciplinary planning.

Briefly stated, protons:
  • Are more precise than conventional radiation therapy and do less damage to normal tissue
  • Reduce side effects both short and long term 
  • Deliver slightly more radiation to the tumor on a dose by dose basis
  • Are effective in treating tumors near sensitive structures such as the spinal cord
  • Can be used to "retreat" some patients with brain cancers
Dr. Lustig noted that Penn is now conducting clinical trials using protons for high-grade glioblastomas, grade III astrocytomas and pituitary adenomas, and will participate in an NCI-RTOG national study on protons for glioblastomas expected to begin soon.

He also noted that many patients encounter insurance issues in trying to get approval for proton therapy, although Medicare pays for most indications.

Stereotactic radiosurgery using the Gamma Knife® is another option for treating brain cancers.  Michelle Alonso-Basanta, MD, PhD, assistant professor of radiation oncology, explained that the original Gamma Knife was not designed to treat cancers, but that advances in technology and technique have made this a useful therapy for some patients with brain cancers.

"As with protons," she says, "we can deliver a very high dose of radiation to the target with little or no exposure of normal tissue to the radiation.  And, as with protons, the decision as to who will benefit from this approach is very individual."

Both stereotactic radiosurgery and protons offer the possibility of retreatment for patients who have undergone a previous course of radiation therapy and whose tumors have recurred.  In the past, these patients were not eligible for additional radiation therapy. 

Targeted Therapies: Changing Cancer Treatment


Penn Medicine has been a leader in immunotherapy research and in developing targeted vaccines for cancer for many years.  Bruce Levine, PhD, facility director, clinical cell and vaccine production facility describes work currently underway that involves activating T-cells, one of the mainstays of the body's defense system, to fight cancers. 

"If I could design T-cells to fight cancer," he says, "they would be potent, have a good memory, be persistent and numerous."

A new approach, developed at Penn, known as CAR (chimeric antigen receptor) T-cell therapy promises to be all of those things.  CAR uses a complex process to remove cells from the patients and own body and activate them to attack the tumor.  Penn is now in the process of developing clinical trials that will study the effects of CAR T cell therapy on glioblastomas with the EGRF v III mutation.

That mutation is the focus of work aimed at improving brain cancer treatment using chemotherapy as well.  Arati Desai, MD, MAS, is using bevacizumab (Avastin), a drug that inhibits blood vessel formation, in combination with another drug in patients with recurrent glioblastomas.  Phase II studies have demonstrated improved response rates and survival, although Desai acknowledges that some controversy exists about what those responses mean in terms of actual survival times.

Other clinical trials are aimed at attacking cancer cells from both the inside of the cell and the outside.

These include approaches using
  • Immunotherapy
  • Combinations of drugs that target multiple pathways
  • Drugs that affect the environment around the tumor
  • Drugs that block the critical M Tors pathway
  • Drugs that target factors known to influence prognosis, such IDH1 and MGMT

"There isn't going to be a single drug or agent that is going to work for everyone," says Desai.  "It's not going to be the same answer for every patient."

Cancer Information From a Reliable Source

Thank you for a fantastic 2012. The Focus On Cancer blog is committed to provide people with cancer and their caregivers educated information from a reliable source, the Abramson Cancer Center at Penn Medicine. Please subscribe to our blog to get updates about new cancer treatments at Penn, credible information from cancer experts at Penn, and inspiration from other people with cancer.
Read more

Comments Off

Making Money Online With Blogs.

Tuesday, December 25, 2012



Everybody wants to make extra money in these times but because of the harsh economical situation it is hard. The good news is that it can be done but it will take a lot of work, one of the easiest way is online the reason for this is because the start up cost is very low.

If you are thinking about getting rich quick please don’t continue to read this post because it won’t help you, if you are willing to work hard and have patient then continue to read. One way to start is to set up a blog; you can do this by going to blogger.com and start a blog in five minutes.


Starting the blog is just the beginning of the work, next you need to identify a topic that you are passionate about and create blog posts about your passion.

 
 
Next step is to market your blog, if you bake the best cake in the world and nobody knows about it you won’t make one cent of it. So that’s where marketing comes into play, ways to market your blog is by using social net works the main ones that I use are facebook and twitter .

What I do is find groups on facebook who have an interest in what I write about and send then links to my site. The most important thing is backlinks, backlinks bring real traffic to your site taken into account that search engines love backlinks.

Find posts that are relevant to your article and leave a link to your site after you have contributed to that post. After you have setup your blog create your posts and market your blog by sending traffic to your site from social networks and backlinks then you can start monetize your blog?

One way to monetize your blog is to run ads on your blog, you can try Google Adsense , google adsense will run ads on your blog and give you apart of the revenue. You can also make money from your blog by selling stuff for Amazon.

That’s just a few ways you can make money online.
Read more

Comments Off

Focus On Cancer Year in Review: New Treatment for Mesothelioma

Monday, December 24, 2012 · Posted in , ,

2012 was an exciting year for the Abramson Cancer Center. We are featuring blogs featured on the Focus On Cancer blog that highlight cancer treatment breakthroughs, coping tips and ideas, education and inspiration. Today, we are highlighting photodynamic therapy for mesothelioma.

Penn was the first health system in the Philadelphia area to begin researching the use of PDT to treat cancer. Also known as photoradiation therapy, phototherapy or photochemotherapy, PDT brings together light-sensitive medication with low-level beams of light to destroy cancer cells.

Mesothelioma Treatment with Photodynamic Therapy

When treating patients with mesothelioma or pleural disease, Penn Medicine lung specialists offer more treatment options than most other health systems across the country and around the world.

One of those treatment options is photodynamic therapy (PDT).

Penn was the first health system in the Philadelphia area to begin researching the use of PDT to treat cancer. Also known as photoradiation therapy, phototherapy or photochemotherapy, PDT brings together light-sensitive medication with low-level beams of light to destroy cancer cells.

Mesothelioma is by definition a disease that is multifocal, meaning it occurs in several places in the lining of the lung simultaneously. This has traditionally made surgery as a treatment for mesothelioma difficult and ineffective.

PDT is used during surgery to increase the effectiveness of the treatment. It works by bringing together a light-sensitive medication with low-level beams of light to destroy cancer cells.  The medication is injected into the bloodstream and absorbed by the cancer cells. A light source is then applied to the area being treated. The light causes the drug to react with oxygen to form a chemical that kills the cancer cells. Photodynamic therapy can also work by destroying the blood vessels that feed the tumor.

PDT can only work in areas that the light can actually reach. It is effective in treating mesothelioma because it is a cancer that affects the lining of the lung. During the surgery, the light is applied to the pleural space, or area surrounding the lungs. Penn researchers continue working on ways to improve PDT’s effectiveness.

Associate Professor of Surgery, Joseph Friedberg, MD, is researchering ways PDT is uses to treat cancer, such as combining PDT with gene therapy or with tumor vaccines to stimulate the immune system to fight cancer.

These are the areas of PDT research today at Penn, and in all likelihood, the innovations of tomorrow that will make mesothelioma easier to treat.

The outlook for mesothelioma patients is improving both in terms of quality and quantity of life, but those improvements depend on being treated at a center that has the expertise and experience to develop the individual treatment plans that are essential to obtaining the best outcomes.
 

Would you like to learn more about treatments for mesothelioma and pleural diseases?

The Penn Mesothelioma and Pleural Program offers a true multidisciplinary approach, presenting patients with essentially all treatment options offered worldwide and a number of treatments offered only at Penn such as PDT.

For more information about the Penn Mesothelioma and Pleural Program, call 215-662-9697.

A dedicated patient navigator will assist you with specific questions about mesothelioma and pleural diseases, and can help you schedule an appointment with a Penn specialist.

Helpful links:

Penn's Abramson Cancer Center is a national cancer center in Philadelphia providing comprehensive cancer treatment, clinical trials for cancer and is a cancer research center. The National Cancer Institute has designated the Abramson Cancer Center a Comprehensive Cancer Center, one of only 40 such cancer centers in the United States.

Cancer Information From a Reliable Source

Thank you for a fantastic 2012. The Focus On Cancer blog is committed to provide people with cancer and their caregivers educated information from a reliable source, the Abramson Cancer Center at Penn Medicine. Please subscribe to our blog to get updates about new cancer treatments at Penn, credible information from cancer experts at Penn, and inspiration from other people with cancer.
Read more

Comments Off

Focus On Cancer Year in Review: The Basser Research Center

Friday, December 21, 2012 · Posted in

2012 was an exciting year for the Abramson Cancer Center. We are featuring blogs featured on the Focus On Cancer blog that highlight cancer treatment breakthroughs, coping tips and ideas, education and inspiration. Today, we are highlighting the Basser Research Center for BRCA.

A $25 million gift to the University of Pennsylvania from alumni Mindy and Jon Gray will establish a center focused on the treatment and prevention of cancers associated with hereditary BRCA mutations.

Basser Research Center for BRCA 1 and 2


A $25 million gift to the University of Pennsylvania from alumni Mindy and Jon Gray will establish a center focused on the treatment and prevention of cancers associated with hereditary BRCA mutations.

The Basser Research Center — BRC for BRCA — will support research on the BRCA1 and BRCA2 genes, harmful forms of which are linked to greatly increased risks of developing breast and ovarian cancer. The Center is named in honor of Mindy Gray’s sister, Faith Basser, who died of ovarian cancer at age 44.

Emphasizing outreach, prevention, early detection, treatment and survivorship, the Basser Research Center will contribute to all stages of research and clinical care related to BRCA-related cancers.

“We hope that the Basser Research Center will eliminate BRCA-related cancers and, in doing so, provide a road map for curing other genetic diseases,” Mindy and Jon Gray said. “We also want to make sure that families have a center dedicated to helping them with the complex issues arising from a BRCA diagnosis. As Penn graduates, we are fortunate that our alma mater has the world-class medical facilities and gifted researchers essential for this mission.”

The Center will be located within Penn’s Abramson Cancer Center at the Perelman School of Medicine. The gift will create an endowed professorship in the field of oncology to be known as the Basser Professorship, recruit additional faculty, enhance core technologies such as bioinformatics and DNA vaccine production, launch an annual lectureship and establish the Basser Prize to honor cutting-edge research.

The Grays’ gift will support research with a particular focus on interdisciplinary work and an acceleration of bench-to-bedside implementation of scientific findings.

Susan Domchek, associate professor of medical oncology and current director of the MacDonald Women’s Cancer Risk Evaluation Center at the Perelman School of Medicine, will serve as the founding executive director of the Basser Research Center and will lead its strategic direction.

Read the full press release about the Basser Research Center.

Learn more about the Basser Research Center.

Cancer Information From a Reliable Source

Thank you for a fantastic 2012. The Focus On Cancer blog is committed to provide people with cancer and their caregivers educated information from a reliable source, the Abramson Cancer Center at Penn Medicine. Please subscribe to our blog to get updates about new cancer treatments at Penn, credible information from cancer experts at Penn, and inspiration from other people with cancer.
Read more

Comments Off

Stay Connected This Holiday Season

· Posted in

Tracy Lautenbach, MSW, LCSW, OSW, is the social work team leader for radiation oncology at Penn. In this article, she reminds those with cancer, or who are cancer survivors, to stay connected to the ones they love this holiday season.

Holidays are traditionally viewed as a time to celebrate with family and friends. 

However, sometimes people with cancer and their loved ones feel they are out of step with the rest of the world during the holidays. Patients and family members wonder how they will be able to take care of themselves while meeting the demands of the season. It is also a time when people become reflective about their illness and the what the future holds form them.

Sharing concerns with the people you love and who are your supports is a way to help you stay connected during this time.


How do you cope with the holiday season? We'd love to hear your suggestions in the comments section below.
Read more

Comments Off

11 Tips for Holiday Eating

Wednesday, December 19, 2012 · Posted in



Debra DeMille, MS, RD, CSO is a nutritional counselor at the Joan Karnell Cancer Center. Debra has worked at Pennsylvania Hospital since 1988 with the last 12 years specializing in oncology. Debra guides individuals receiving chemotherapy and radiation as well as addressing survivorship issues including the use of integrative therapies.


She conducts cooking programs and group counseling sessions for cancer survivors.
You do not have to abandon all of your efforts for a healthier lifestyle because of the riches of the holidays. Take care of yourself over this next month in order to keep energized. Here are some ideas to get your started.
  • Planning is the key. As you plan when you have company, plan healthy eating and exercise in advance. Keep healthy food in your refrigerator.
  • Stay well rested and stay true to your exercise program.
  • Eat before you go out shopping or visiting. Avoid being in a position where a meal is skipped due to a hectic schedule. When out at the mall, resist picking up a treat as a pick me up. It may just be that you are need of a glass of water.
  • Eat regularly scheduled meals – don’t skip a meal to save yourself for a big event. This only results in over eating.
  • When at parties or at buffets:
    • Survey the food options before picking up a plate.
    • Decide what foods you would enjoy the most instead of trying to eat it all. If you are on a modified diet, this will help keep the “overages” in reason.
    • Only eat foods that look fresh. Are the hot items in a buffet on a heating element? Are cold items on ice? This is particularly important for those with impaired immunity.
    • Avoid all drinks or salad dressings with raw egg such as eggnog or Caesar salad dressing.
  • Eat to your comfort level. Avoid being excessively hungry or uncomfortably full.
  • Don’t decorate your house with food. It’s too tempting to reach for the cookie tray.
  • Consider abstaining from alcohol. Combining alcohol and medications can cause some serious side effects.
Most of all, enjoy the time that brings people together and start out the new year ahead of the game.
Read more

Comments Off

Using Cinnamon To Treat Diabetes Naturally

Tuesday, December 18, 2012

 
The search for effective treatments for diabetes, especially type 2 diabetes, remains a challenge for medical researchers, regardless of their background. As many of you know, many of the oral medications have significant side effects that are not popular with patients, have limited effectiveness, or lack evidence of impacting the course of the disease, including the development of complications. This challenge, combined with an increasing interest in herbal and complementary medicine has led to a search for effective natural therapies that have significant effects on blood sugar levels, blood pressure, etc.
Diabetes Action Research and Education Foundation is the only diabetes organization to specifically prioritize research funding to universities and researchers committed to discovering and evaluating effective natural therapies to help combat diabetes! Your support of Diabetes Action and its research efforts is greatly appreciated, as you and the ones you love will benefit from their contributions to advancing research on natural choices and healthy lifestyles- critical to long-term success in managing diabetes.

Cinnamon, the brown, mildly bitter, mild spicy cooking herb, has gained popularity as an herbal treatment for diabetes because it is readily available and relatively inexpensive. Since this original publication, several others have studied cinnamon in different groups of people and challenged the original findings, while additional publications suggested the type of cinnamon and/or how the extract was made may be significant factors in the effects cinnamon has on blood sugar. Also, many research publications have focused on laboratory measures, which are important in diabetes, but do not fully account for risk; some publications suggest cinnamon may have other benefits, like antioxidant effects and production against "type 3 diabetes" or insulin resistance in the brain. In this article I will review the recent clinical evidence on cinnamon, and provide some guidance on if you should try it yourself!
What Makes Cinnamon "Work"?
Cinnamon contains rather high levels of compounds called "polyphenols"1. Polyphenols refer to the chemical structure of an entire class of compounds that have rather high antioxidant activity, and are typically very effective in reducing the oxidative processes that change fats and lipids into potent inflammatory compounds (e.g. peroxidation). Cinnamon is not the only food/herbal medicine that has high amounts of these polyphenols; other examples include green tea, darkly colored berries, red grapes, some nuts including peanuts, and dark chocolate. Translational research by Roussel et al. supports the antioxidant effects of a water-soluble cinnamon extract (a preparation method that concentrates polyphenols) 2. Some recent studies suggest, for safety and better efficacy, that the water-soluble compounds in cinnamon are the most effective, however good clinical research has not yet compared this extract (and commercially available product) to the whole herb3.

Does Clinical Research Support Cinnamon as an Effective Treatment?
A publication by Dr. Khan and Dr. Anderson reported research supported by Diabetes Action that suggested cinnamon reduced blood sugar for patients with type 2 diabetes.
The first significant clinical study evaluating Cinnamon was published by Khan et al. in 2003.4 In this trial, 60 Pakistani participants took Cinnamon (Cinnamon cassia) orally for 40 days at three different doses (1, 3, or 6 grams per day).After 40 days, significant reductions in fasting blood sugar, cholesterol (including LDL or "bad" cholesterol) and triglycerides were noted at each dose, although the group receiving the 6 grams per day dose did have a larger percent reduction in blood glucose compared to the 1 and 3 gram per day dosing groups (29% vs. ~25%). One limitation in this study is that the results may not be applicable to all people, as the trial was performed in Pakistan, where dietary intake of polyphenol compounds is quite limited, and thus introducing dietary polyphenols in such significant amounts may have different effects than it would in groups of people with more diverse dietary intake of polyphenol compounds, including the United States. The flip side of this criticism is that people in Pakistan are relatively medication naive and take fewer supplements, thus creating a nice "blank slate" for research that avoids potential confounders.
The next trial, published by Mang, et al. in 2006, evaluated a water-soluble extract, corresponding to 3 grams of cinnamon, in 79 German participants with type 2 diabetes for four months.5 Although fasting glucose was lowered at the end of the trial, the reductions were modest compared to the findings by Khan et al.; average reductions were about 10%. Unlike the findings of Khan et al., changes in cholesterol and triglycerides were not significant, nor were changes in hemoglobin A1c.
Additional clinical research on cinnamon was published by Suppapitiporn et al. also in 2006.6 In their clinical trial, 60 Thai participants with type 2 diabetes took 1.5 grams per day of encapsulated whole cinnamon powder or placebo for 3 months. At the end of the trial period, no significant changes were evident in either fasting glucose, hemoglobin A1c or lipids. There was suggestion that a greater percentage of patients in the cinnamon group achieved glucose "control" (i.e. reached a hemoglobin A1c value of < 7%), however this difference (35% vs. 15%) was not statistically significant.
cinnamon sticksThe saga continues with the clinical trial published by Vanschoonbeek et al. in which 25 post-menopausal women with type 2 diabetes, from the Netherlands, were randomized to take either 1.5 grams of ground, whole herb cinnamon or placebo for 6 weeks.
Evaluating the effectiveness of cinnamon at the end of 2006 would have led, I'm afraid, to an assessment of "not effective" based on rather small and highly variable fasting glucose reductions seem across studies. Fear not, we only had to wait a year to get more evidence!


In 2007, Altschuler et al. published the first available clinical trial of cinnamon in participants with type 1 diabetes.8 In this trial, 72 adolescents with type 1 diabetes were randomized to receive either 1 gram/day of cinnamon or placebo for 3 months. At the end of the trial period, no significant changes in hemoglobin A1c, insulin sensitivity, or daily insulin use (units/day). In fact, insulin use actually increased in the cinnamon group. It is important to differentiate this study from the other studies discussed above. Type 1 diabetes is a very different condition than type 2, with different causative factors and pathogenesis. It may be possible that the polyphenols of cinnamon have a sensitizing effect on insulin only in the presence of significant insulin resistance (this may be due to the role lipid peroxides have on inducing insulin resistance, which may be improved with antioxidant polyphenol supplementation).
cinnamon can improve insulin sensitivity in healthy adults, how this evidence applies to people with diabetes is less clear...

In hopes of addressing the limitations in the trial by Khan et al., specifically the population in the study, in 2007 Blevins et al. published the results of their clinical trial performed in the United States.9 In their study, 60 participants with type 2 diabetes and very stable medications were randomly assigned to take cinnamon (1 gram per day) or placebo for 3 months. At the end of 3 months, there were no significant changes in fasting glucose, hemoglobin A1c, insulin, insulin sensitivity or lipid values. Notably a considerable percentage of the participants (~75%) in this trial were taking insulin sensitizing medications, which may have over-powered any modest action of the cinnamon extract.


As you have probably noticed, many researchers attempted to replicate the findings of Khan et al in different populations, but using similar doses, i.e. 1-1.5 grams/day. However, the basis for the dosing in the original trial wasn't specific, rather it was a somewhat arbitrary attempt at performing a dose-response study, and therefore, although reasonable to try these doses again, new research exploring even higher doses stopped until the 2007 publication by Solomon et al.10 In their study, 7 healthy adults without diabetes performed three oral glucose tolerance tests (An oral glucose tolerance test (OGTT) is performed by having a patient drink a standardized solution containing 75 grams of glucose, and then measuring insulin and glucose simultaneously for several hours following. The values are then plotted as a curve; the area under the curve provides meaningful reflections of glucose tolerance and can be used to estimate insulin sensitivity.) preceded by 5 grams of cinnamon, 5 grams of placebo, or 5 grams of cinnamon given 12-hours before the OGTT. Their results demonstrated significant reductions in post-OGTT blood glucose corresponding to measured improvements in insulin sensitivity.

Solomon et al. continued their translational research evaluating the effects of high dose cinnamon powder on insulin sensitivity in healthy adults by evaluating the effects of sustained short-term intake (3 grams per day or placebo for 14 days) on glucose and insulin measures also following OGTT.11 In this study, cinnamon reduced blood glucose following the OGTT, reduced insulin response to the OGTT and improved insulin sensitivity compared with the placebo. However, the effects were lost however almost immediately upon stopping the cinnamon extract.
Although these small, translational trials provide "proof of concept" evidence, i.e. cinnamon can improve insulin sensitivity in healthy adults, how this evidence applies to people with diabetes is less clear. First of all, the dose used here, 3 and 5 grams per day, are very large. One concern I have is the differences in liver health in "healthy" adults vs. adults with diabetes. As many patients with diabetes also suffer from elevated liver enzymes due to a condition of increased fat deposition in the liver (a condition called non-alcohol steatohepatitis (NASH) or "fatty liver" disease), the effects of such large doses of cinnamon on liver health should be studied more before doses of cinnamon this large are considered for routine use.
...a greater reducation in A1c was evident in the cinnamon group...this finding was highly statistically significant.


Although the clinical trials that have been published on cinnamon generally show very few, if any, side effects, none of these trials have reported very systematic approaches to measuring side effects and none of the studies provide evidence of safety based on laboratory results.
Just when findings were starting to look really quite bleak for a role of cinnamon in lowering blood sugar in people with diabetes, Dr. Crawford published a clinical trial (apparently performed all by himself) evaluating the impact of whole-herb cinnamon (Cinnamon cassia, 1 gram per day for 3 months) vs. placebo in 109 patients with type 2 diabetes recruited from three primary care clinics on a US military base. Cinnamon was added to normal medications and medication changes were not meaningfully different between groups at the end of the study. In this clinical trial, a ~0.5% greater reduction in hemoglobin A1c was evident in the cinnamon group compared to the placebo group; this finding was highly statistically significant. This trial is notable for several reasons, including its size (the largest randomized trial performed thus far) and its "Western" participant group from a typical clinical practice setting.
Read more

Comments Off

Recovery for Brain Cancer and the New Normal

· Posted in

Christine Wilson, cancer survivor, shares her experiences from the Abramson Cancer Center’s 2012- Focus on Brain Cancer Conference. In this blog, she discusses recovery from brain cancer and accepting a “new normal.”

"You are not alone." - Arbena Merolli, MSW, social worker at the Abramson Cancer Center

For some brain cancer patients, there comes a day when active treatment ends. That day can bring with it a myriad of mixed feelings, relief, happiness, anxiety and uncertainty. The end of treatment does not mean the end of the experience of having brain cancer.

Many people, even those who have been treated successfully, experience short and long term symptoms and effects of their treatment. These can include seizures, fatigue, memory loss, weakness and ongoing anxiety or depression. Some have physical or neurocognitive deficits that prevent them from returning to their old jobs or participating in activities that were previously important parts of their lives.

The second half of Focus on Brain Cancer Conference brought together a diverse group - nurses, nurse practitioners, social workers and a team of experts in integrative medicine--as well patients to address these issues, and the "new normal" that comes with them.

Redirect

While some brain cancer patients return to their jobs, others find that they have to make changes. The panel of Arbena Merolli, MSW, Karen Albright, MSN, CRNP, and Lisa Lycksell, MSN, CRNP, conference panelists emphasized there are effective ways of controlling many symptoms, but that, in some instance, people have to "redirect," and learn to compensate. That may mean having a less stressful job, or one with shorter hours. For those who struggle with short memory issues, learning to take notes or write lists and reminders is often helpful. The panel urged patients who cannot return to work to find the things they love to do such as hobbies, activities and volunteer work. They also encouraged people to take advantage of available resources and get counseling to help them adjust to life after active treatment.

The three survivors who followed made those recommendations real and personal. One has had to modify his work life since his diagnosis five years ago, but now teaches CPR--and volunteers with his seven pound dog, Killer, as a pet therapist.

Another fights short term memory loss, but it has not kept him from getting his PhD in biology and teaching high school in the 21 years since he had a seizure on New Year's Eve and later learned that it was caused by a brain tumor.

And another survivor’s journey began in 2008 when she developed psychiatric symptoms, and had to insist to her doctor that "something was wrong with my brain," before getting the CT scan that revealed her tumor. Two years later, she repeated that struggle, this time with her insurance company before learning she had a recurrence. In that time, though, she has had two children and started a successful business.
Read more

Comments Off

Patient Story: Proton Therapy for Non-Small Cell Lung Cancer

Monday, December 17, 2012 · Posted in ,

Kathy Brandt was diagnosed with non-small cell lung cancer in 2011 at her local hospital. After much research, and a recommendation from her brother-in-law, who is a physician, Kathy chose Penn Medicine for her lung cancer treatment, which included proton therapy. Today, Kathy is cancer free. 

Watch Kathy Brandt, a patient alum, tell her story about proton therapy for lung cancer. 

You hear the words cancer and it's truly terrifying.

It was basically just a checkup with my pulmonologist because I have emphysema. He sent me for a chest X-ray and that is when they found the tumor in my lung.

It was a terrifying time and thankfully I had strong family surrounding me - strong family helping me make decisions about what kind of treatment I should have.

After that initial diagnosis, when you feel like you have been hit with a ton of bricks, then the decision needs to be made where you are going to seek treatment. My brother-in-law, who is a physician, along with my pulmonologist suggested I go to Penn Medicine for treatment.

Penn Medicine was a wonderful choice for us. They used a team approach. I saw an oncologist, I saw a surgeon, and the radiologist is all located at Penn Medicine. It was very comforting to know that all these people are just working to take care of you and to make you better.

I was diagnosed with non-small cell lung cancer at the end of June. My surgery was the beginning of August and chemo started in September. It was finished in November. I started proton therapy for lung cancer in December, which lasted for 4 weeks.

Deciding to Have Proton Therapy for Non-Small Cell Lung Cancer

I decided to go with the proton radiation because of the cancer’s proximity to my heart and spine. I chose proton therapy because I knew it would be more precise and would have less side effects and that was very important to me.

The Proton Therapy Experience

Every day, I would leave work, come home, and my husband would take me to Penn for proton therapy. After the treatment, we’d go home and I’d spend time with my grandchildren and their parents, who were living with us at the time. My granddaughter was about 3 months old at the time. And I would take her, feed her, and just spend time with the people that meant the most to me.

I really felt wonderful. I continued to work the whole time I had proton therapy – I never missed a day of work, actually. I was a bit more tired than usual, but that was really the only side effect I felt.

When I completed proton therapy, I rang the bell. Everybody in the waiting room clapped, and we went home and I think I had a very big glass of wine after treatment was finished.

After Proton Therapy

Today, I don’t sweat the small stuff.

I would tell anyone to feel very comfortable going to Penn Medicine, and I would tell anyone to also feel very comfortable in choosing proton therapy simply because of the fewer side effects and its extreme precision. I would recommend Penn Medicine wholeheartedly. I cannot say enough good things about my experience.

Learn More About Proton Therapy for Non-Small Cell Lung Cancer at Penn Medicine

Proton therapy is a non-invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy the DNA of cancer cells killing them and preventing them from multiplying.

Unlike conventional radiation that can affect surrounding healthy tissue as it enters the body and targets the tumor, proton therapy’s precise, high dose of radiation is extremely targeted. This targeted precision causes less damage to healthy, surrounding tissue.

Learn more about proton therapy, or schedule a consultation with a radiation oncologist at Penn Medicine.

Watch the full video of Kathy's experience here. 

Read more

Comments Off

Man shot and kill 26 at a Connecticut elementary school

Friday, December 14, 2012


NEWTOWN, Conn. (AP) — A man opened fire Friday inside two classrooms at the Connecticut elementary school where his mother was a teacher, killing 26 people, including 20 children, as youngsters cowered in corners and closets and trembled helplessly to gunshots reverberating through the building.

The 20-year-old killer, carrying two handguns, committed suicide at the school, and another person was found dead at a second scene, bringing the toll to 28, authorities said.
Police shed no light on the motive for the attack. The gunman was believed to suffer from a personality disorder and lived with his mother in Connecticut, said a law enforcement official who was briefed on the investigation but was not authorized to publicly discuss it.


rampage, coming less than two weeks before Christmas, was the nation's second-deadliest school shooting, exceeded only by the Virginia Tech massacre that left 33 people dead in 2007.
Panicked parents looking for their children raced to Sandy Hook Elementary School in Newtown, a prosperous community of about 27,000 people 60 miles northeast of New York City. Youngsters at the kindergarten-through-fourth-grade school were told to close their eyes by police as they were led from the building.

Schoolchildren — some crying, others looking frightened — were escorted through a parking lot in a line, hands on each other's shoulders.
"Our hearts are broken today," a tearful President Barack Obama, struggling to maintain composure, said at the White House. He called for "meaningful action" to prevent such shootings.
Youngsters and their parents described teachers locking doors and ordering the children to huddle in the corner or hide in closets when shots echoed through the building. Authorities didn't say exactly how the shootings unfolded.



They also gave no details on the victim discovered at another scene, except to say that the person was an adult found dead by police while they were investigating the gunman.
A law enforcement official identified the gunman as 20-year-old Adam Lanza, the son of a teacher. A second law enforcement official said his mother, Nancy Lanza, was presumed dead.
Adam Lanza's older brother, 24-year-old Ryan, of Hoboken, N.J., was being questioned.

The law enforcement official who said Adam Lanza had a possible personality disorder said Ryan Lanza had been extremely cooperative, was not believed to have any involvement in the rampage and was not under arrest or in custody, but investigators were still searching his computers and phone records. Ryan Lanza told law enforcement he had not been in touch with his brother since about 2010.

All three law enforcement officials spoke on the condition of anonymity because they were not authorized to speak on the record about the unfolding investigation.
The gunman drove to the school in his mother's car, the second official said. Three guns were found — a Glock and a Sig Sauer, both pistols, inside the school, and a .223-caliber rifle in the back of a car.
State police Lt. Paul Vance said 28 people in all were killed, including the gunman, and one person was injured.

Robert Licata said his 6-year-old son was in class when the gunman burst in and shot the teacher.
"That's when my son grabbed a bunch of his friends and ran out the door," he said. "He was very brave. He waited for his friends."
He said the shooter didn't utter a word.
Stephen Delgiadice said his 8-year-old daughter was in the school and heard two big bangs. Teachers told her to get in a corner, he said.


"It's alarming, especially in Newtown, Connecticut, which we always thought was the safest place in America," he said. His daughter was fine.
Mergim Bajraliu, 17, heard the gunshots echo from his home and ran to check on his 9-year-old sister at the school. He said his sister, who was fine, heard a scream come over the intercom at one point. He said teachers were shaking and crying as they came out of the building.
"Everyone was just traumatized," he said.

Mary Pendergast, who lives close to the school, said her 9-year-old nephew was in the school at the time of the shooting, but wasn't hurt after his music teacher helped him take cover in a closet.
Richard Wilford's 7-year-old son, Richie, is in the second grade at the school. His son told him that he heard a noise that "sounded like what he described as cans falling."
The boy told him a teacher went out to check on the noise, came back in, locked the door and had the kids huddle up in the corner until police arrived.

"There's no words," Wilford said. "It's sheer terror, a sense of imminent danger, to get to your child and be there to protect him."
On Friday afternoon, family members were led away from a firehouse that was being used as a staging area, some of them weeping. One man, wearing only a T-shirt without a jacket, put his arms around a woman as they walked down the middle of the street, oblivious to everything around them.
Another woman with tears rolling down her face walked by carrying a car seat with a young infant inside and a bag that appeared to have toys and stuffed animals.

"Evil visited this community today and it's too early to speak of recovery, but each parent, each sibling, each member of the family has to understand that Connecticut — we're all in this together. We'll do whatever we can to overcome this event," Gov. Dannel Malloy said.
Adam Lanza and his mother lived in a well-to-do part of Newtown where neighbors are doctors or hold white-collar positions at companies such as General Electric, Pepsi and IBM.
The shootings instantly brought to mind episodes such as the Columbine High School massacre that killed 15 in 1999 and the July shootings at a movie theater in Aurora, Colo., that left 12 dead.

"You go to a movie theater in Aurora and all of a sudden your life is taken," Columbine principal Frank DeAngelis said. "You're at a shopping mall in Portland, Ore., and your life is taken. This morning, when parents kissed their kids goodbye knowing that they are going to be home to celebrate the holiday season coming up, you don't expect this to happen. I think as a society, we need to come together. It has to stop, these senseless deaths."

Obama's comments on the tragedy amounted to one of the most outwardly emotional moments of his presidency.
"The majority of those who died were children — beautiful, little kids between the ages of 5 and 10 years old," Obama said.
He paused for several seconds to keep his composure as he teared up and wiped an eye. Nearby, two aides cried and held hands as they listened to Obama.
"They had their entire lives ahead of them — birthdays, graduations, wedding, kids of their own," Obama continued about the victims. "Among the fallen were also teachers, men and women who devoted their lives to helping our children."
___
Associated Press writers Jim Fitzgerald and Pat Eaton-Robb in Newtown, Samantha Henry in Newark, N.J., Pete Yost in Washington and Michael Melia in Hartford contributed to this report
Read more

Comments Off

HEADStrong Foundation Feeds Cancer Patients and Families at Penn

This November marked the 6th year the HEADstrong Foundation prepared and served a traditional Thanksgiving dinner to several floors of patients and families who are amidst treatment for blood cancer in the Rhoads Pavilion at Hospital of the University of Pennsylvania.

About the HEADStrong Foundation

The HEADstrong Foundation for blood cancer is committed to finding a cure for all blood cancers. The foundation is dedicated to its founder Nicholas Colleluori, who was diagnosed with non-Hodgkin lymphoma in 2005, and passed away in November, 2006.

The foundation strives on Nick’s quote, “Making use of the time you have and don’t stress the little things. Have a smile and enjoy what you can get out of life.”

Read more about the HEADStrong Foundation's founder.

Helping Patients with Blood Cancer and Their Families

Preparing, serving, and sharing the feast is just one way that the HEADstrong Foundation improves the quality of life for patients and families battling blood cancers. They also support lymphoma research taking place at the Abramson Cancer Center under the leadership of Stephen J. Schuster, MD.

This annual tradition which began as a Thanksgiving feast, is turning into an exciting new program, called HEAD’s Table. HEAD’s Table will expand their outreach into the blood cancer community through the nurturing act of serving a meal to patients, their families and medical personnel four times a year- March, June, November and December.


Thanks to HEADstrong for all that they do for the patients, faculty, and staff of the Abramson Cancer Center.
Read more

Comments Off

Prisoner plotted to kill Justin Bieber


ALBUQUERQUE, New Mexico (AP) — An imprisoned man whose infatuation with Justin Bieber included a tattoo of the pop star on his leg has told investigators in New Mexico he hatched a plot to kill the singer, according to documents recently filed in a New Mexico court.
An affidavit filed in Las Cruces said Dana Martin told investigators he persuaded a man he met in prison and the man's nephew to kill Bieber, along with Bieber's personal bodyguard and two others not connected to the pop star.


The plot contained several gruesome details. Investigators say the plotters wanted to castrate two of the victims with hedge clippers before traveling to New York City to find Bieber. The targets of the castration plot were not connected to Bieber, authorities say, and it doesn't appear that the pop singer was ever in immediate danger of falling victim to the plot.
Martin, a Vermont man who is serving two life sentences for the 2000 killing of a 15-year-old girl, said he was angry at Bieber because he didn't respond to any of his letters. "This perceived slight made Mr Martin upset and that, coupled with Mr Martin's perception of being a `nobody' in prison, led him to begin plotting the kidnap and murder of Victim 3," court documents said.
Martin told investigators that Mark Staake,41, and Tanner D. Ruane,23, headed from New Mexico to the East Coast, planning to be near a Bieber concert scheduled in New York City after killing and castrating two others. But authorities say they missed a turn and crossed into Canada from Vermont. Staake was arrested on an outstanding warrant. Ruane was arrested later.
Court documents say Martin told investigators that Bieber was the "ultimate target." No one was killed in the alleged elaborate plot.
Clinton Norris, of the New Mexico State Police investigations bureau in Las Cruces, said in an affidavit that Martin instructed the suspects to strangle the two first intended targets with paisley neckties, the same kind used in his 2000 murder case.

Read more

Comments Off
Powered by Blogger.